Domov › Debelost › Arizona › Phoenix
Klinične študije za Debelost v Phoenix, AZ
22 študij za Debelost išče udeležence na lokacijah v Phoenix in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Early Tracking of Childhood Health Determinants (ETCHED) Study
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- NIDDK, Phoenix, Phoenix
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Vključevanje udeležencevFaza 3
- RIO Clinical Trials - Phoenix, Phoenix
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Vključevanje udeležencevFaza 3
- Research Site, Phoenix
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Vključevanje udeležencevFaza 3
- Synexus Clinical Research US, Inc., Phoenix
- Medical Advancement Centers of Arizona, Phoenix
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Vključevanje udeležencevFaza 3
- Elite Clinical Studies, LLC, Phoenix
Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
Vključevanje udeležencevVabljeni zdravi prostovoljci
- NIDDK, Phoenix, Phoenix
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Vključevanje udeležencevFaza 3
- AURORA-1 Clinical Site, Phoenix
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Vključevanje udeležencevFaza 3
- AURORA-2 Clinical Site, Phoenix
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Vključevanje udeležencevFaza 3
- HonorHealth, Phoenix
- Medical Advancement Centers of Arizona, Phoenix
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Vključevanje udeležencevFaza 2
- Helios Clinical Research - Phoenix, Phoenix
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Vključevanje udeležencevFaza 3Vabljeni zdravi prostovoljci
- ACCOMPLISH-2 Research Site, Phoenix
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
Vključevanje udeležencevFaza 2
- Synexus Clinical Research US, Inc., Phoenix
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Vključevanje udeležencevFaza 4
- Medical Dermatology Specialists, Phoenix
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Vključevanje udeležencevFaza 3
- Kailera Clinical Site, Phoenix
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Vključevanje udeležencevFaza 3
- Kailera Clinical Site, Phoenix
The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure
Vključevanje udeležencevVabljeni zdravi prostovoljci
- NIDDK, Phoenix, Phoenix
Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity
Vključevanje udeležencevOpazovalna študija
- Exponent Phoenix, Phoenix
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Vključevanje udeležencevFaza 3
- Honor Health, Phoenix
- Arizona Research Center, Phoenix
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Vključevanje udeležencevFaza 3
- ACCOMPLISH-1 Research Site, Phoenix
Fibrosis Lessens After Metabolic Surgery
Vključevanje udeležencevFaza 4Vabljeni zdravi prostovoljci
- Banner Health Center, Phoenix
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Vključevanje udeležencevFaza 3
- Arizona Research Center, Inc., Phoenix
Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
Vključevanje udeležencevFaza 3
- The University of Arizona College of Medicine- Phoenix, Phoenix
Študije za Debelost v drugih mestih
- Houston, TX43 študij
- Chicago, IL41 študij
- New York City, NY40 študij
- San Antonio, TX40 študij
- Washington, DC33 študij
- Orlando, FL31 študij
- Dallas, TX30 študij
- Boston, MA28 študij
- Las Vegas, NV27 študij
- Miami, FL27 študij
- Baltimore, MD25 študij
- Jacksonville, FL25 študij
Druge študije v Phoenix
- Rak dojke25 študij
- Kolorektalni rak25 študij
- Nemalicelični pljučni rak20 študij
- Metastatski rak20 študij
- Srčno popuščanje18 študij
- Rak prostate17 študij
- Rak (vse vrste)17 študij
- Množni mielom16 študij
- Rak trebušne slinavke16 študij
- Srčno-žilne bolezni16 študij
- Alzheimerjeva bolezen15 študij
- Prekomerna telesna teža15 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.